CANADABIS CAPITAL INC (CANB.CA) Fundamental Analysis & Valuation

TSX-V:CANB • CA13530Q1046

Current stock price

0.015 CAD
+0 (+50%)
Last:

This CANB.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CANB.CA Profitability Analysis

1.1 Basic Checks

  • CANB had negative earnings in the past year.
  • CANB had a negative operating cash flow in the past year.
  • In multiple years CANB reported negative net income over the last 5 years.
  • CANB had negative operating cash flow in 4 of the past 5 years.
CANB.CA Yearly Net Income VS EBIT VS OCF VS FCFCANB.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

1.2 Ratios

  • The Return On Assets of CANB (-5.26%) is comparable to the rest of the industry.
  • CANB has a Return On Equity (-16.69%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 1.62%, CANB is in the better half of the industry, outperforming 65.63% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CANB is above the industry average of 9.14%.
  • The 3 year average ROIC (12.44%) for CANB is well above the current ROIC(1.62%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -5.26%
ROE -16.69%
ROIC 1.62%
ROA(3y)6.13%
ROA(5y)0.44%
ROE(3y)19.38%
ROE(5y)-14.57%
ROIC(3y)12.44%
ROIC(5y)N/A
CANB.CA Yearly ROA, ROE, ROICCANB.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • The Operating Margin of CANB (1.90%) is better than 65.63% of its industry peers.
  • CANB's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 45.50%, CANB perfoms like the industry average, outperforming 59.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CANB has grown nicely.
Industry RankSector Rank
OM 1.9%
PM (TTM) N/A
GM 45.5%
OM growth 3Y-28.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y5.67%
CANB.CA Yearly Profit, Operating, Gross MarginsCANB.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CANB.CA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CANB is creating value.
  • CANB has about the same amout of shares outstanding than it did 1 year ago.
  • CANB has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CANB is higher compared to a year ago.
CANB.CA Yearly Shares OutstandingCANB.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CANB.CA Yearly Total Debt VS Total AssetsCANB.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • CANB has an Altman-Z score of 0.15. This is a bad value and indicates that CANB is not financially healthy and even has some risk of bankruptcy.
  • CANB's Altman-Z score of 0.15 is in line compared to the rest of the industry. CANB outperforms 50.00% of its industry peers.
  • A Debt/Equity ratio of 1.00 is on the high side and indicates that CANB has dependencies on debt financing.
  • CANB has a Debt to Equity ratio of 1.00. This is in the lower half of the industry: CANB underperforms 78.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACC0.32
WACC5.15%
CANB.CA Yearly LT Debt VS Equity VS FCFCANB.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

  • CANB has a Current Ratio of 1.33. This is a normal value and indicates that CANB is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.33, CANB is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
  • CANB has a Quick Ratio of 1.33. This is a bad value and indicates that CANB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.27, CANB is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.27
CANB.CA Yearly Current Assets VS Current LiabilitesCANB.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CANB.CA Growth Analysis

3.1 Past

  • The earnings per share for CANB have decreased strongly by -720.00% in the last year.
  • CANB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.84%.
  • The Revenue has been growing by 30.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.13%
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y13.14%
Revenue growth 5Y30.72%
Sales Q2Q%-35.88%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CANB.CA Yearly Revenue VS EstimatesCANB.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

Find the best growth stocksShow best growing peers

1

4. CANB.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CANB. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CANB.CA Price Earnings VS Forward Price EarningsCANB.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CANB indicates a rather cheap valuation: CANB is cheaper than 84.38% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.92
CANB.CA Per share dataCANB.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 0.04 0.06 0.08 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CANB.CA Dividend Analysis

5.1 Amount

  • CANB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CANB.CA Fundamentals: All Metrics, Ratios and Statistics

CANADABIS CAPITAL INC

TSX-V:CANB (4/9/2026, 7:00:00 PM)

0.015

+0 (+50%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength29.13
Industry Growth47.76
Earnings (Last)04-06
Earnings (Next)06-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners51.84%
Ins Owner ChangeN/A
Market Cap2.12M
Revenue(TTM)15.08M
Net Income(TTM)-1.29M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.27
EV/EBITDA 6.92
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.11
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -5.26%
ROE -16.69%
ROCE 2.15%
ROIC 1.62%
ROICexc 1.73%
ROICexgc 1.73%
OM 1.9%
PM (TTM) N/A
GM 45.5%
FCFM N/A
ROA(3y)6.13%
ROA(5y)0.44%
ROE(3y)19.38%
ROE(5y)-14.57%
ROIC(3y)12.44%
ROIC(5y)N/A
ROICexc(3y)15.4%
ROICexc(5y)N/A
ROICexgc(3y)15.4%
ROICexgc(5y)N/A
ROCE(3y)15.95%
ROCE(5y)N/A
ROICexgc growth 3Y-38.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y-38.64%
ROICexc growth 5YN/A
OM growth 3Y-28.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.68%
GM growth 5Y5.67%
F-Score1
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA 6.65
Cap/Depr 7.85%
Cap/Sales 0.46%
Interest Coverage 0.86
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 0.27
Altman-Z 0.15
F-Score1
WACC5.15%
ROIC/WACC0.32
Cap/Depr(3y)67.82%
Cap/Depr(5y)55.13%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-720%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-139.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.84%
Revenue growth 3Y13.14%
Revenue growth 5Y30.72%
Sales Q2Q%-35.88%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.84%
EBIT growth 3Y-19.31%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-161.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-147.44%
OCF growth 3YN/A
OCF growth 5YN/A

CANADABIS CAPITAL INC / CANB.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for CANADABIS CAPITAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to CANB.CA.


What is the valuation status of CANADABIS CAPITAL INC (CANB.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to CANADABIS CAPITAL INC (CANB.CA). This can be considered as Overvalued.


Can you provide the profitability details for CANADABIS CAPITAL INC?

CANADABIS CAPITAL INC (CANB.CA) has a profitability rating of 4 / 10.